These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 17682099
1. A novel insertion sequence, ISPA26, in oprD of Pseudomonas aeruginosa is associated with carbapenem resistance. Evans JC, Segal H. Antimicrob Agents Chemother; 2007 Oct; 51(10):3776-7. PubMed ID: 17682099 [No Abstract] [Full Text] [Related]
3. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B. APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762 [Abstract] [Full Text] [Related]
4. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem. Farra A, Islam S, Strålfors A, Sörberg M, Wretlind B. Int J Antimicrob Agents; 2008 May; 31(5):427-33. PubMed ID: 18375104 [Abstract] [Full Text] [Related]
5. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy. Wolter DJ, Acquazzino D, Goering RV, Sammut P, Khalaf N, Hanson ND. Clin Infect Dis; 2008 Jun 15; 46(12):e137-41. PubMed ID: 18462098 [Abstract] [Full Text] [Related]
6. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. Riera E, Cabot G, Mulet X, García-Castillo M, del Campo R, Juan C, Cantón R, Oliver A. J Antimicrob Chemother; 2011 Sep 15; 66(9):2022-7. PubMed ID: 21653605 [Abstract] [Full Text] [Related]
7. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates. Naenna P, Noisumdaeng P, Pongpech P, Tribuddharat C. Southeast Asian J Trop Med Public Health; 2010 May 15; 41(3):614-24. PubMed ID: 20578550 [Abstract] [Full Text] [Related]
8. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Lee JY, Ko KS. Int J Antimicrob Agents; 2012 Aug 15; 40(2):168-72. PubMed ID: 22633564 [Abstract] [Full Text] [Related]
11. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan. Sanbongi Y, Shimizu A, Suzuki T, Nagaso H, Ida T, Maebashi K, Gotoh N. Microbiol Immunol; 2009 Jul 15; 53(7):361-7. PubMed ID: 19563394 [Abstract] [Full Text] [Related]
14. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. Wolter DJ, Hanson ND, Lister PD. FEMS Microbiol Lett; 2004 Jul 01; 236(1):137-43. PubMed ID: 15212803 [Abstract] [Full Text] [Related]
15. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals. Kim CH, Kang HY, Kim BR, Jeon H, Lee YC, Lee SH, Lee JC. J Microbiol; 2016 Jan 01; 54(1):44-49. PubMed ID: 26727901 [Abstract] [Full Text] [Related]
17. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele. Shu JC, Su LH, Chiu CH, Kuo AJ, Liu TP, Lee MH, Su IN, Wu TL. Microb Drug Resist; 2015 Apr 01; 21(2):149-57. PubMed ID: 25386722 [Abstract] [Full Text] [Related]